MedPath

Pharynx Analgesia Before Upper Gastrointestinal Endoscopy

Not Applicable
Completed
Conditions
Upper Gastrointestinal Endoscopy
Interventions
Drug: Xilocaine Spray Arm
Drug: Strepsils Intensiv plus Xilocaine spray Arm
Registration Number
NCT06220175
Lead Sponsor
Carol Davila University of Medicine and Pharmacy
Brief Summary

This is a comparative study on patient and endoscopist experience during upper gastrointestinal endoscopy with NSAIDs (flurbiprofen) topical analgesia plus xilocaine spray topical anesthesia of the pharynx versus xilocaine spray topical anesthesia of the pharynx alone, before procedure.

Detailed Description

Upper gastrointestinal endoscopy may be done with topical anesthesia of the pharynx with xilocaine spray, with conscious sedation with midazolam or with general anesthesia with propofol. In Romania, the endoscopist may only offer topical pharyngeal anesthesia, any other sedation or anesthesia needs the presence of an anesthesiologist on premises.

Xilocaine spray improves the gag reflux and the satisfaction score of the patient as well as the ease of insertion and the satisfaction score of the endoscopist.

A study published in 2010 has compared the tolerance of upper GI endoscopy in patients in which the topical anesthesia of the pharynx has been done using Strepsils Plus with xilocaine versus xilocaine spray. The group of patients with Strepsils Plus had a significantly lower tolerance, lower anesthesia score, a higher gag score and a higher disconfort score versus patients in group with xilocaine spray.

Nevertheless, topical pharyngeal anesthesia with benzocaine spray and in much lesser degree with xilocaine spray may lead to a very rare adverse reaction, namely methemoglobinemia. That is why, an safer alternative to xilocaine spray would be desirable at this moment.

Question at which the research protocol is trying to answer The investigators intent to evaluate whether a topical pharyngeal anti inflammatory molecule, a non steroidal anti inflammatory drug (NSAID), that is Strepsils Intensive with honey and lemon which contains flurbiprofen 8.75mg before upper GI endoscopy plus xilocaine spray improves the satisfaction score of the patient as compared to standard xilocaine spray alone.

Hypothesis A topical NSAID will improve the satisfaction score of the patient during upper GI endoscopy, when added to xilocaine spray.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • Patient with indication of upper gastrointestinal endoscopy with topical pharyngeal anesthesia with xilocaine spray
  • Age above 18 years
  • Informed consent
Exclusion Criteria
  • Allergy to xilocaine and/or flurbiprofen
  • Absence of informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Xilocaine Spray ArmXilocaine Spray ArmThe patient will have pharyngeal topical xilocaine spray before upper GI endoscopy, 5 puffs in two applications immediately before examination.
Strepsils Intensiv Arm + Xilocaine SprayStrepsils Intensiv plus Xilocaine spray ArmPatient will take one pill of Strepsils Intensiv containing 8.75mg flurbiprofen 10 to 15 minutes before endoscopy. The patient will have pharyngeal topical xilocaine spray before upper GI endoscopy, 5 puffs in two applications immediately before examination.
Primary Outcome Measures
NameTimeMethod
Patient satisfaction score24 hours

Evaluation on visual score 0 - 10 (0 - minimum, 10 - maximum)

Secondary Outcome Measures
NameTimeMethod
Patient pain score24 hours

Evaluation on visual score 0 - 10 (0 - minimum, 10 - maximum)

Endoscopist satisfaction score24 hours

Evaluation on visual score 0 - 10 (0 - minimum, 10 - maximum)

Patient gag score24 hours

Evaluation on visual score 0 - 10 (0 - minimum, 10 - maximum), by the endoscopist

Patient discomfort score24 hours

Evaluation on visual score 0 - 10 (0 - minimum, 10 - maximum)

Trial Locations

Locations (1)

"Agrippa Ionescu" Hospital

🇷🇴

Bucharest, Romania

© Copyright 2025. All Rights Reserved by MedPath